Javascript must be enabled to continue!
Donor DMEK Tissue Characteristics: Association With Rebubble Rate and 6-Month Endothelial Cell Loss
View through CrossRef
Purpose:
To determine whether specific donor characteristics influence postoperative rebubble rate and 6-month endothelial cell loss (ECL) in Descemet membrane endothelial keratoplasty (DMEK).
Methods:
A retrospective analysis of a consecutive series of 857 DMEK surgeries using eye bank-prepared donor tissue was performed between September 2013 and April 2018. DMEK graft characteristics including donor age, preoperative endothelial cell density (ECD), preservation time, death-to-preservation time, and donor diabetes status were analyzed for correlation with rebubble rate and 6-month postoperative ECL. Subgroup analyses of donor age, preoperative ECD, preservation time, death-to-preservation time, preparation-to-surgery time, and diabetes severity were also performed. Statistically significant relationships between donor characteristics and rebubble rate or 6-month postoperative ECL were determined using Pearson correlation, one-way analysis of variance, t test, and χ2 analysis.
Results:
The overall rate of rebubble after 857 surgeries performed by 7 surgeons during the study period was 12.6%. There was no significant relationship between postoperative rebubble rate and donor age, preoperative ECD, preservation time, death-to-preservation time, preparation-to-surgery time, or donor diabetes status. The subgroup analysis of these characteristics also yielded no significant relationship with rebubble rate. There was also no significant relationship between 6-month postoperative ECL and analyzed donor factors.
Conclusions:
Donor characteristics such as higher donor age, lower preoperative ECD (<2500), longer preservation time, and donor diabetes did not increase the rebubble rate or the 6-month ECL after DMEK. These results indicate that common surgeon preferences for donor tissues that are younger, fresher, with higher cell count, and without diabetes do not translate into superior postsurgical outcomes.
Ovid Technologies (Wolters Kluwer Health)
Title: Donor DMEK Tissue Characteristics: Association With Rebubble Rate and 6-Month Endothelial Cell Loss
Description:
Purpose:
To determine whether specific donor characteristics influence postoperative rebubble rate and 6-month endothelial cell loss (ECL) in Descemet membrane endothelial keratoplasty (DMEK).
Methods:
A retrospective analysis of a consecutive series of 857 DMEK surgeries using eye bank-prepared donor tissue was performed between September 2013 and April 2018.
DMEK graft characteristics including donor age, preoperative endothelial cell density (ECD), preservation time, death-to-preservation time, and donor diabetes status were analyzed for correlation with rebubble rate and 6-month postoperative ECL.
Subgroup analyses of donor age, preoperative ECD, preservation time, death-to-preservation time, preparation-to-surgery time, and diabetes severity were also performed.
Statistically significant relationships between donor characteristics and rebubble rate or 6-month postoperative ECL were determined using Pearson correlation, one-way analysis of variance, t test, and χ2 analysis.
Results:
The overall rate of rebubble after 857 surgeries performed by 7 surgeons during the study period was 12.
6%.
There was no significant relationship between postoperative rebubble rate and donor age, preoperative ECD, preservation time, death-to-preservation time, preparation-to-surgery time, or donor diabetes status.
The subgroup analysis of these characteristics also yielded no significant relationship with rebubble rate.
There was also no significant relationship between 6-month postoperative ECL and analyzed donor factors.
Conclusions:
Donor characteristics such as higher donor age, lower preoperative ECD (<2500), longer preservation time, and donor diabetes did not increase the rebubble rate or the 6-month ECL after DMEK.
These results indicate that common surgeon preferences for donor tissues that are younger, fresher, with higher cell count, and without diabetes do not translate into superior postsurgical outcomes.
Related Results
Rate of Endothelial Cell Loss and Graft Survival in Descemet Membrane Endothelial Keratoplasty in Eyes Requiring a Rebubble
Rate of Endothelial Cell Loss and Graft Survival in Descemet Membrane Endothelial Keratoplasty in Eyes Requiring a Rebubble
Purpose:
We aimed to compare the rate of 6-month endothelial cell loss (ECL) and 6-month graft survival in eyes that did not require a postoperative rebubble with eyes ...
Five-Year Endothelial Cell Density Outcomes After DMEK Using Peripherally Versus Centrally Trephinated Donor Tissue
Five-Year Endothelial Cell Density Outcomes After DMEK Using Peripherally Versus Centrally Trephinated Donor Tissue
Purpose:
To compare 5-year endothelial cell density (ECD) outcomes after Descemet membrane endothelial keratoplasty (DMEK) using peripherally trephinated donor ...
Clinical Outcomes of Descemet Membrane Endothelial Keratoplasty in Pseudophakic Eyes Compared With Triple-DMEK at 1-Year Follow-up
Clinical Outcomes of Descemet Membrane Endothelial Keratoplasty in Pseudophakic Eyes Compared With Triple-DMEK at 1-Year Follow-up
Purpose:
To compare the survival rate 1 year after Descemet membrane endothelial keratoplasty (DMEK) in pseudophakic eyes versus combined phacoemulsification and DMEK (...
Descemet Membrane Endothelial Keratoplasty for Endothelial Failure in Primary Angle Closure Suspects
Descemet Membrane Endothelial Keratoplasty for Endothelial Failure in Primary Angle Closure Suspects
Purpose:
To analyze the feasibility and outcome of Descemet membrane endothelial keratoplasty (DMEK) for treatment of endothelial failure in primary angle closure suspe...
Outcomes of Pseudophakic, Phakic, and Triple DMEK
Outcomes of Pseudophakic, Phakic, and Triple DMEK
Purpose:
To evaluate the outcome of phakic and pseudophakic eyes treated by Descemet membrane endothelial keratoplasty (DMEK) versus DMEK combined with cataract surgery...
Preparation of Donor Descemet Membrane Endothelial Keratoplasty Tissue Under Age 50 Compares Favorably With Older Tissue
Preparation of Donor Descemet Membrane Endothelial Keratoplasty Tissue Under Age 50 Compares Favorably With Older Tissue
Purpose:
Corneal tissue shortage is an ongoing concern for corneal surgeons and eye banks across the United States. Descemet membrane endothelial keratoplasty (...
Younger Donor Tissue in Descemet Membrane Endothelial Keratoplasty Surgery: Clinical Outcomes
Younger Donor Tissue in Descemet Membrane Endothelial Keratoplasty Surgery: Clinical Outcomes
Purpose:
To determine whether using younger donor tissue for Descemet membrane endothelial keratoplasty (DMEK) surgery influences clinical outcomes.
...
Scheimpflug Densitometry After DMEK Versus DSAEK—Two-Year Outcomes
Scheimpflug Densitometry After DMEK Versus DSAEK—Two-Year Outcomes
Purpose:
To compare the course of Scheimpflug corneal densitometry (CD) after Descemet membrane endothelial keratoplasty (DMEK) versus Descemet stripping automated endo...

